Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Strabismus And Amblyopia Digital Therapeutics Market Expected To Become By 2029 Compared With Its 2025 Level?
The strabismus and amblyopia digital therapeutics market has experienced significant expansion in recent years. It is projected to grow from $0.55 billion in 2024 to $0.61 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.1%. The market’s past growth can be attributed to several factors, including increasing research and development in digital eye therapy, government support for healthcare innovation, expanding health insurance coverage for digital health solutions, a rising focus on personalized medicine, and enhanced awareness of amblyopia and strabismus.
The strabismus and amblyopia digital therapeutics market is anticipated to experience swift expansion over the coming years. By 2029, its valuation is projected to reach $0.93 billion, exhibiting a compound annual growth rate (CAGR) of 10.9%. This projected increase during the forecast period stems from factors such as the increasing incidence of strabismus and amblyopia, a heightened preference for non-invasive treatment options, enhanced availability of telemedicine and remote healthcare, a greater emphasis on early diagnosis and intervention, and an expanding elderly demographic. Key developments expected within this period encompass progress in digital therapeutics technology, enhancements in the design of digital applications for ocular health, strategic alliances between tech firms and healthcare entities, the integration of wearable devices in eye care, and advancements in digital diagnostic tools for eye conditions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24409&type=smp
Which Factors And Drivers Are Influencing The Strabismus And Amblyopia Digital Therapeutics Market In 2025?
The expansion of telehealth is projected to stimulate the growth of the strabismus and amblyopia digital therapeutics market moving forward. Telehealth utilizes digital communication technologies to deliver healthcare services, consultations, and patient monitoring remotely between individuals and healthcare providers. Its increasing prevalence stems from improved access to healthcare, enabling patients, particularly those residing in remote or underserved areas, to consult with specialists and receive treatment without requiring travel or physical appointments. Telehealth provides crucial support for strabismus and amblyopia digital therapeutics by facilitating continuous remote monitoring and guidance, which allows patients, especially children, to engage in consistent and supervised therapy from the comfort of their homes. For example, according to Rock Health, a US-based digital health company, 80% of US people had accessed care via telemedicine at some point in their lives, marking an 8 percentage point increase from 72% in 2021. 22, 2022. Consequently, the continued expansion of telehealth will drive the growth of the strabismus and amblyopia digital therapeutics market.
What Are The Segment Types Shaping The Strabismus And Amblyopia Digital Therapeutics Market?
The strabismus and amblyopia digital therapeuticsmarket covered in this report is segmented –
1) By Type: Software; Hardware
2) By Indication: Strabismus (Crossed Eyes); Amblyopia (Lazy Eye)
3) By Application: Hospital; Ophthalmic Clinic; Other Applications
Subsegments:
1) By Software: Mobile Applications; Virtual Reality (VR) Applications; Augmented Reality (AR) Applications; Web-Based Platforms; Cloud-Based Software
2) By Hardware: Wearable Devices; Visual Stimulus Devices; Headsets; Eye-Tracking Devices; Light Therapy Devices
How Are Trends Influencing The Strabismus And Amblyopia Digital Therapeutics Market?
Leading companies within the strabismus and amblyopia digital therapeutics market are concentrating on developing technologically advanced solutions, such as digital therapy devices, to improve eye coordination and visual acuity through interactive exercises. A digital therapy device is defined as a software-based tool or platform created to address medical conditions via interactive exercises and behavioral interventions delivered through digital platforms. For instance, in April 2022, NovaSight, an Israel-based medical device company, announced that its CureSight, a digital therapy device designed to treat amblyopia (lazy eye), had received clearance from the US Food and Drug Administration (FDA). This eye-tracking system works to enhance visual and stereo acuity by training both eyes to cooperate. The FDA’s approval was based on findings from a multicenter, randomized, controlled study that involved 103 kids between the ages of 4 and 9. Participants in the study were randomly provided with either the CureSight gadget or conventional eye patching, which represents the current accepted standard of care. The positive visual outcomes from the trial affirmed the device’s utility.
Who Are The Major Companies Operating In The Strabismus And Amblyopia Digital Therapeutics Market?
Major companies operating in the strabismus and amblyopia digital therapeutics market are 3M Company, Freedom Scientific Inc., Ocutrx Vision Technologies LLC, Orthoptics Australia Inc., Good-Lite Company, AmblyoPlay, NovaSight Ltd., Luminopia Inc., NeuraSim Health, Bynocs Inc., RevitalVision LLC, Vivid Vision Inc., Binovi Technologies Corp., Wow Vision Therapy, OculoMotor Technologies Inc., Web Vision Therapy, CureSee Vision Therapy, AnteoTech Ltd, VisionBuilder, HTS Vision Therapy Systems
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Strabismus And Amblyopia Digital Therapeutics Industry?
North America was the largest region in the strabismus and amblyopia digital therapeutics market in 2024. The regions covered in the strabismus and amblyopia digital therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Strabismus And Amblyopia Digital Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24409&type=smp
Browse Through More Reports Similar to the Global Strabismus And Amblyopia Digital Therapeutics Market 2025, By The Business Research Company
Eye Health Supplements Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-health-supplements-global-market-report
Eye Melanoma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report
Eye Tracking Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/eye-tracking-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model